Adam Oliensis Profiles S&P 500 Index; and Highlights Abbott Labs, DaimlerChrysler, Yahoo, and Genentech.Business Editors CHICAGO--(BUSINESS WIRE)--April 11, 2003 Adam Oliensis can teach you how to move as fast as the market through technical analysis that includes stock and index profiles. Get his expert commentary and market recommendations in this Featured Expert article. Get information on S&P 500 Index (CIN CIN cervical intraepithelial neoplasia. Cervical intraepithelial neoplasia (CIN) A term used to categorize degrees of dysplasia arising in the epithelium, or outer layer, of the cervix. :SPX (Sequenced Packet EXchange) The transport layer protocol in the NetWare operating system. Similar to the TCP layer in TCP/IP, it ensures that the entire message arrives intact. SPX uses NetWare's IPX as its delivery mechanism. ), Abbott Laboratories (NYSE NYSE See: New York Stock Exchange :ABT), DaimlerChrysler (NYSE:DCX), Yahoo (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :YHOO), and Genentech (NYSE:DNA DNA: see nucleic acid. DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. ). Click here for the full story exclusively on Zacks.com: http://featuredexpert2bw.zacks.com/ Here are the highlights from the Featured Expert column: Sentiment may just be emerging from a very wonky won·ky adj. won·ki·er, won·ki·est Chiefly British 1. Shaky; feeble. 2. Wrong; awry. [Probably alteration of dialectal wanky, alteration of wankle period, what with the war and all...and now earnings arriving. At this stage Adam Oliensis looks to be in for some mid-term weakness with subsequent longer term underlying strength emerging after that weakness. Abbott Laboratories (NYSE:ABT) met first quarter earnings expectations of $801 million (or 51 cents per share Cents per share The amount of a mutual fund's dividend or capital gains distributions that a shareholder will receive for each share owned. ), meeting consensus estimates. DaimlerChrysler (NYSE:DCX) reaffirmed its 2003 target to increase operating profits, acknowledged it would be a strain. After the close on Wednesday, Yahoo (NASDAQ:YHOO) reported a profit of $0.08 for Q1, $0.02 better than estimates. Revenues rose 47% Y/Y to $283M, above estimates of $273M. Genentech (NYSE:DNA) reported Q1 pro-forma earnings of $0.35 per share, $0.07 better than consensus of $0.28 (GAAP GAAP See: Generally Accepted Accounting Principles GAAP See generally accepted accounting principles (GAAP). EPS (Encapsulated PostScript) A PostScript file format used to transfer a graphic image between applications and platforms. EPS files contain PostScript code as well as an optional preview image in TIFF, WMF, PICT or EPSI, the latter being an ASCII-only format. was $0.29); revenues rose 32% Y/Y to $750M, $8M better than estimates. The S&P 500 Index (CIN:SPX) broke below its congestion The condition of a network when there is not enough bandwidth to support the current traffic load. congestion - When the offered load of a data communication path exceeds the capacity. in the 870s, below the old neckline at 875 and is now in the process of testing a variety of support notions between 848 and 855. Should 848 break, then Oliensis will be looking for a test of the 800 area. In order to get bullish again, we'd have to move above the 877-880 range. Don't miss out on your chance to stay active through Adam Oliensis' technical analysis of the market and sentiment everyday by clicking: http://featuredexpert3bw.zacks.com/ About Zacks Featured Experts To be a successful investor you need professional advice. Experts who know what they're talking about and can help you achieve your financial goals in good markets...and especially in bad ones will help you improve your portfolio. That is why Zacks Investment Research Zacks Investment Research A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms. has assembled the best investment experts in the business to offer their powerful advisory newsletters to you on all the major investment topics: Stocks, Mutual Funds, Bonds, Options, Futures etc. Recommendations from Featured Experts Highlighted in FREE Investment Newsletter The best way to tap into the powerful advice from these experts is through our free weekly e-mail newsletter, "Profit from the Pros". Each week we highlight several Featured Experts in this free e-mail newsletter. Get your free subscription to "Profit from the Pros" at: http://www.freeprofit1bw.zacks.com About Zacks Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1981 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind our work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. Our goal is to unlock their profitable insights for our customers. And there is no better way to enjoy this investment success, than with a FREE subscription to "Profit from the Pros" weekly e-mail newsletter. For your free newsletter, visit http://www.freeprofitbw.zacks.com Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion